KRAS and thyroid cancer: Our study reveals that the expression levels of BRAF, EIF1 AX, FOXE1, KRAS, PDGFRA, PIK3 CA, PTEN, and TERT are significantly down-regulated in thyroid cancer cell lines compared to controls.